PROGNOSTIC VALUE OF BIOMARKERS FOR THE DURATION OF INPATIENT TREATMENT IN CHILDREN WITH COVID-19
DOI:
https://doi.org/10.32345/USMYJ.3(164).2026.73-81Keywords:
COVID-19, biomarker, NSE, S100, E-selectin, IFABP, NGAL, children, duration of hospitalization, bed daysAbstract
Introduction. COVID-19 in children usually has a mild or moderate course, but in some patients, it is associated with a prolonged clinical course and requires longer hospitalization. Identification of early prognostic biomarkers may improve clinical assessment and prognostic stratification of the disease.
Aim. The aim of the study was to determine the prognostic significance of the biomarkers NSE, S100, IFABP, NGAL, and E-selectin for the duration of inpatient treatment in children with COVID-19 to facilitate individualized treatment strategies.
Materials and methods. This retrospective comparative observational study included 88 children with laboratory-confirmed COVID-19 who were hospitalized in 2022-2023. Patients were divided into two groups according to the duration of hospitalization: ≤5 days (n=47) and >5 days (n=41). Serum levels of NSE, S100, IFABP, NGAL, and E-selectin were determined by ELISA during hospitalization. Statistical analysis was performed using the licensed statistical software EZR (version 1.54), including the Mann–Whitney U test, Pearson’s χ² test, Spearman’s correlation analysis, and ROC analysis with determination of the area under the curve (AUC), sensitivity, and specificity. The statistical significance level was set at p<0.05.
Results. Children hospitalized for more than 5 days had higher levels of IFABP and NGAL than those with a shorter hospital stay (p<0.05). According to the ROC analysis, the highest predictive value for prolonged hospitalization was demonstrated by IFABP (AUC=0.791) and NGAL (AUC=0.719), whereas E-selectin showed moderate predictive performance (AUC=0.663), and NSE and S100 showed limited predictive performance (AUC=0.591 and AUC=0.582, respectively). Correlation analysis confirmed statistically significant positive associations between the duration of hospitalization and the levels of IFABP (ρ=0.623; p=0.009), NGAL (ρ=0.611; p=0.01), and E-selectin (ρ=0.408; p=0.004).
Conclusions. IFABP and NGAL are the most informative predictors of the duration of inpatient treatment in children with COVID-19. E-selectin has additional moderate prognostic value, whereas NSE and S100 have limited prognostic value. Elevated levels of IFABP, NGAL, and E-selectin are associated with longer hospitalization and may potentially serve as predictors of a prolonged disease course; however, these findings require further confirmation in prospective multicenter studies.
References
1. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. 2026. https://covid19.who.int/
2. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020 Jun;145(6):e20200702. https://doi.org/10.1542/peds.2020-0702
3. Zimmermann P, Curtis N. Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. Pediatr Infect Dis J. 2020 May;39(5):355-368. https://doi.org/10.1097/INF.0000000000002660.
4. Rabaan AA, Smajlović S, Tombuloglu H, Ćordić S, Hajdarević A, Kudić N, Al Mutai A, Turkistani SA, Al-Ahmed SH, Al-Zaki NA, Al Marshood MJ, Alfaraj AH, Alhumaid S, Al-Suhaimi E. SARS-CoV-2 infection and multi-organ system damage: A review. Biomol Biomed. 2023 Feb 1;23(1):37-52. https://doi.org/10.17305/bjbms.2022.7762.
5. Ewing AG, Salamon S, Pretorius E, Joffe D, Fox G, Bilodeau S, Bar-Yam Y. Review of organ damage from COVID and Long COVID: a disease with a spectrum of pathology. Med Rev (2021). 2024 Jul 2;5(1):66-75. https://doi.org/10.1515/mr-2024-0030.
6. Xu SW, Ilyas I, Weng JP. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin. 2023 Apr;44(4):695-709. https://doi.org/10.1038/s41401-022-00998-0.
7. Liu A, Hammond R, Donnelly PD, Kaski JC, Coates ARM. Effective prognostic and clinical risk stratification in COVID-19 using multimodality biomarkers. J Intern Med. 2023 Jul;294(1):21-46. https://doi.org/10.1111/joim.13646
8. Saia RS, Giusti H, Luis-Silva F, Pedroso KJB, Auxiliadora-Martins M, Morejón KML, Degiovani AM, Cadelca MR, Basile-Filho A. Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection. Int J Infect Dis. 2021 Dec;113:82-86. https://doi.org/10.1016/j.ijid.2021.09.051.
9. Savarraj J, Park ES, Colpo GD, Hinds SN, Morales D, et al. Brain injury, endothelial injury and inflammatory markers are elevated and express sex-specific alterations after COVID-19. J Neuroinflammation;2021,18(1):277. https://doi.org/10.1186/s12974-021-02323-8.
10. Isgrò MA, Bottoni P, Scatena R. Neuron-specific enolase as a biomarker: biochemical and clinical aspects. Adv Exp Med Biol;2015, 867:125–43
11. Zarei H, Roshdi Dizaji S, Toloui A, Yousefifard M, Esmaeili A. Diagnostic and Prognostic Values of S100B versus Neuron Specific Enolase for Traumatic Brain Injury; a Systematic Review and Meta-analysis. Arch Acad Emerg Med. 2024 Feb 18;12(1):e29. https://doi.org/10.22037/aaem.v12i1.2222
12. Romejko K, Markowska M, Niemczyk S. The Review of Current Knowledge on Neutrophil Gelatinase-Associated Lipocalin (NGAL). Int. J. Mol. Sci. 2023, 24, 10470. https://doi.org/10.3390/ijms241310470
13. Onuk S, Ozer NT, Sahin Ergul S, Eryilmaz Eren E, Karakukcu C, Sipahioglu H, Karayol Akin A, Gundogan K. Could serum intestinal fatty acid-binding protein and citrulline levels be predictive markers of mortality in critically ill COVID-19 patients? J Infect Dev Ctries. 2025 Jul 28;19(7):1024-1029. https://doi.org/10.3855/jidc.20862.
14. Abbas Q, Laghari P, Jurair H, Nafis J, Saeed B, Qazi MF, Saleem A, Khan AHH, Haque A. Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Acute Kidney Injury in Children With Shock: A Prospective Study. Cureus. 2023 Jan 30;15(1):e34407. https://doi.org/10.7759/cureus.34407
15. Zou Z, Chen B, Tang F, Li X, Xiao D. Predictive value of neutrophil gelatinase-associated lipocalin in children with acute kidney injury: A systematic review and meta-analysis. Front Pediatr. 2023 Mar 27;11:1147033. https://doi.org/10.3389/fped.2023.1147033
16. Shi H, Zuo Y, Navaz S, Harbaugh A, Hoy CK, Gandhi AA, Sule G, Yalavarthi S, Gockman K, Madison JA, Wang J, Zuo M, Shi Y, Maile MD, Knight JS, Kanthi Y. Endothelial Cell-Activating Antibodies in COVID-19. Arthritis Rheumatol. 2022 Jul;74(7):1132-1138. https://doi.org/10.1002/art.42094
17. Sahin BE, Celikbilek A, Kocak Y, Saltoglu GT, Konar NM, Hizmali L. Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms. J Neurol Sci. 2022 Aug 15;439:120324. https://doi.org/10.1016/j.jns.2022.120324.
18. Rabczyński M, Chwałek S, Adamiec-Mroczek J, Lewandowski Ł, et al. Neutrophil Elastase, Neuron-Specific Enolase, and S100B Protein as Potential Markers of Long-Term Complications Caused by COVID-19 in Patients with Type 2 Diabetes Mellitus (T2DM) and Advanced Stage of Diabetic Nephropathy (NfT2DM)-Observational Studies. Int J Mol Sci. 2024 Nov 2;25(21):11791. https://doi.org/10.3390/ijms252111791.
19. Bigot-Corbel E, Lanore A, Raulet C, Delorme C, et al. SARS-CoV-2 and neurological disorders: the revelance of biomarkers?. Ann Biol Clin (Paris). 2021 Feb 1;79(1):7-16. French. https://doi.org/10.1684/abc.2021.1622.
20. Tyszko M, Lipińska-Gediga M, Lemańska-Perek A, Kobylińska K, Gozdzik W, Adamik B. Intestinal Fatty Acid Binding Protein (I-FABP) as a Prognostic Marker in Critically Ill COVID-19 Patients. Pathogens. 2022; 11(12):1526. https://doi.org/10.3390/pathogens11121526
21. Tsounis EP, Triantos C, Konstantakis C, Marangos M, Assimakopoulos SF. Intestinal barrier dysfunction as a key driver of severe COVID-19. World J Virol. 2023 Mar 25;12(2):68-90. https://doi.org/10.5501/wjv.v12.i2.68.
22. Xu K, Shang N, Levitman A, Corker A, Kudose S, et al. Elevated Neutrophil Gelatinase-Associated Lipocalin Is Associated With the Severity of Kidney Injury and Poor Prognosis of Patients With COVID-19. Kidney Int Rep. 2021 Dec;6(12):2979-2992. https://doi.org/10.1016/j.ekir.2021.09.005.
23. Engström J, Koozi H, Didriksson I, Larsson A, Friberg H, Frigyesi A, Spångfors M. Plasma neutrophil gelatinase-associated lipocalin independently predicts dialysis need and mortality in critical COVID-19. Sci Rep. 2024 Mar 20;14(1):6695. https://doi.org/10.1038/s41598-024-57409-z.
24. Orea-Tejada A, Sánchez-Moreno C, Aztatzi-Aguilar OG, Sierra-Vargas MP, et al Plasma Endothelial and Oxidative Stress Biomarkers Associated with Late Mortality in Hospitalized COVID-19 Patients. J Clin Med. 2022 Jul 7;11(14):3950. https://doi.org/10.3390/jcm11143950.
25. Oliva A, Rando E, Al Ismail D, De Angelis M, et al. Role of Serum E-Selectin as a Biomarker of Infection Severity in Coronavirus Disease 2019. J Clin Med. 2021 Sep 6;10(17):4018. https://doi.org/10.3390/jcm10174018.
26. Kokkoris S, Stamataki E, Emmanouil G, Psachoulia C, et al. Serum inflammatory and brain injury biomarkers in COVID-19 patients admitted to intensive care unit: A pilot study. eNeurologicalSci. 2022 Dec;29:100434. https://doi.org/10.1016/j.ensci.2022.100434
ISSN 
ISSN 
